The rise of venture philanthropy

Venture philanthropists are guided by one simple principle: get useful treatments into the hands of patients, and make money doing it. In LifeArc’s case, those returns come from the stakes it holds in the companies it invests in, and sharing the royalties of successful treatments. These returns are then reinvested back into other potential treatments, creating sustainable cash flow for the charity and a financial incentive for companies and start-ups to research particular diseases. More often than not, the charities will act as partners as well as investors, offering ongoing consultation and guidance.

Read the full article.